Globus Medical, Inc.

NYSE:GMED

Medical - Devices

Healthcare
$70.53 -2.71%

-$2.10 today

Market cap
$9.34B
Beta
0.95
P/E (TTM)
17.4
EPS (TTM)
$4.33
52W Low $51.79High $101.40

Volume 1.43M

Average 1.45M

GMED Revenue

Total income from selling goods and services before any costs are deducted; the top line of the income statement.

Globus Medical, Inc.NYSE: GMED

Revenue · Q2 FY2026 · quarter ended Jun 2026

Revenue grows, but more slowly than its trailing trend

Q2 FY2026 revenue of $789.61M rose 5.9% year over year, behind the +19.7% change in trailing-twelve-month revenue. Sequentially, it rose 3.9% from the prior quarter. Over 3 fiscal years it compounded at +42.2% a year.

Context

  • Revenue increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether revenue reaches the consensus estimate from 11 analysts of $3.1B (+5.5%) for the fiscal year ending Dec 2026, a slowdown from the +16.7% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
$789.61M+3.9% QoQ
Last fiscal yearDec 2025
$2.94B+16.7% YoY
LTMJun 2026
$3.14B+19.7% YoY
Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+5.9%+3.0%-2.9 pp
1 year+16.7%+5.5%-11.2 pp
3-year CAGR+42.2%+5.4%-36.7 pp
5-year CAGR+8.1%—
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Revenue history

USD · from the income statement

Latest · FY2025
2.94B USD
Year-over-year change
+16.7%
4-year CAGR
+32.3%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Revenue vs competitors

How GMED compares with its peers on the latest reported figures

  • GMED's LTM Jun 2026 revenue of $3.14B is the 4th highest of the 10 companies compared; the peer median is $787.08M.
  • Its year-over-year change of +19.7% is the 2nd highest of 10, against a peer median of +8.5%.
  • Over three fiscal years its annual growth of +42.2% compares with a peer median of +21.3%.
GMED Competitors Peer median
Revenue for GMED and competitors
Company Period LTM YoY 3-year CAGR
SYKStryker CorporationLTM Jun 2026$25.84B +8.5%+10.8%
ZBHZimmer Biomet Holdings, Inc.LTM Jun 2026$8.51B +8.6%+5.9%
SNNSmith & Nephew plcFY2025$6.16B +6.1%+5.7%
GMEDGlobus Medical, Inc.LTM Jun 2026$3.14B +19.7%+42.2%
OFIXOrthofix Medical Inc.LTM Mar 2026$825.37M +2.6%+21.3%
ATECAlphatec Holdings, Inc.LTM Mar 2026$787.08M +22.5%+29.6%
BVSBioventus Inc.LTM Mar 2026$576.3M +1.5%+3.5%
KIDSOrthoPediatrics Corp.LTM Mar 2026$243.3M +14.5%+24.6%
SIBNSI-BONE, Inc.LTM Mar 2026$206.22M +16.8%+23.6%
XTNTXtant Medical Holdings, Inc.LTM Mar 2026$121.91M -0.3%+32.2%
Peer median (excluding GMED) $787.08M+8.5%+21.3%

Competitors are the stored peer set for GMED. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue958.1M1.02B1.57B2.52B2.94B
Cost of Revenue239.22M263.73M548.17M1.04B957.8M
Gross Profit718.88M759.12M1.02B1.48B1.98B
Gross Margin75.0%74.2%65.1%58.9%67.4%
Research & Development97.35M73.02M124.01M163.75M185M
Selling, General & Admin408.15M432.12M643.41M981.05M1.32B
Operating Expenses546.93M531.17M887.16M1.32B1.5B
Depreciation & Amortization69.87M68.25M144.73M254.02M276.84M
EBITDA264.73M304.5M346.58M473.73M886.74M
EBITDA Margin27.6%29.8%22.1%18.8%30.2%
Operating Income171.95M227.95M133.14M165.99M479.8M
Operating Margin17.9%22.3%8.5%6.6%16.3%
Interest Income9.3M14.23M20.13M07.14M
Interest Expense0004.19M0
Other Income / Expenses8.45M15.07M32.25M(45.27M)130.1M
Income Before Tax180.41M243.02M165.39M120.72M609.9M
Pre-Tax Margin18.8%23.8%10.5%4.8%20.8%
Income Tax Expense31.22M52.85M42.52M17.74M72M
Net Income149.19M190.17M122.87M102.98M537.9M
Net Margin15.6%18.6%7.8%4.1%18.3%
EPS (Basic)1.481.891.090.763.98
EPS (Diluted)1.441.851.070.753.92
Weighted Avg Shares100.73M100.47M113.09M135.73M135.15M
Weighted Avg Shares (Diluted)103.62M102.64M114.63M137.86M137.22M

Globus Medical, Inc.

NYSE:GMED

Intrinsic Alpha fair value

Locked

Current Price

$70.53

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.